EQS-News: Esperas Pharma Inc. / Key word(s): Investment Esperas Pharma, Inc. Announces Investment from TVM Life Science Innovation I and The Fonds de solidarité FTQ 21.02.2023 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. Esperas Pharma, Inc. Announces I.
MIL-OSI: TVM Capital Life Science Announces Creation of LAmAb Biologics to Develop Innovative Preventative Therapy for Allergy Patients foreignaffairs.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foreignaffairs.co.nz Daily Mail and Mail on Sunday newspapers.
EQS-News: TVM Life Science Management GmbH / Key word(s): Investment TVM Capital Life Science Announces Creation of LAmAb Biologics to Develop Innovative Preventative Therapy for Allergy Patients 08.02.2023 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. T.
08.02.2023 - EQS-News: TVM Life Science Management GmbH / Key word(s): Investment TVM Capital Life Science Announces Creation of LAmAb Biologics to Develop Innovative Preventative Therapy for Allergy Patients 08.02.2023 / 14:00 CET/CEST The issuer is solely . Seite 1